Form 4 for SER Serina Therapeutics, Inc.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-11 · accession 0001209191-21-069617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-14 | 2021-12-11 | SER | WEST MICHAEL D | CEO, Dir | F - Tax | $0.64 | -1,081 | 38.6K | -3% | -$691.84 |
| D | 2021-12-14 | 2021-12-11 | SER | WEST MICHAEL D | CEO, Dir | M - OptEx | $0.00 | +3,125 | 39.7K | +9% | $0 |
| D | 2021-12-14 | 2021-12-11 | SER | WEST MICHAEL D | CEO, Dir | M - OptEx | $0.00 | -3,125 | 15.6K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2021-12-11 | F | D | 1,081 | $0.64 | 38,571 | D | — | — | |
| 2 | Common | Common Stock, $0.0001 par value | 2021-12-11 | M | A | 3,125 | $0.00 | 39,652 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-12-11 | M | D | 3,125 | $0.00 | 15,625 | D | $0.00 · — to — | 3,125 Common Stock | (F2) Restricted Stock Units vested on December 11, 2021. |